Li-Min Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Li-Min Xie has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Xin Yin
Department of Clinical Laboratory Medicine The Third Affiliated Hospital of Guangzhou Medical University Guangzhou China
2 shared publications - Xu-Guang Guo
Department of Clinical Medicine, The Third Clinical School of Guangzhou Medical University, Guangzhou, China
2 shared publications - Huanmin Kang
Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China
1 shared publication - Ji-Yuan Zeng
Department of Pediatrics The Pediatrics School of Guangzhou Medical University Guangzhou China
1 shared publication - Jian-Wen Su
Department of Clinical Laboratory Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
1 shared publication - Jing-Hao Zhang
Department of Clinical Laboratory Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
1 shared publication
Latest Publications
- Open Access
- 19 May 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (9) , 1870-1883
Tacrolimus prolongs corneal allograft survival and prevents dendritic cell infiltration in a myeloid-derived suppressor cell–dependent manner
- 19 May 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (9) , 1870-1883
Open AccessTacrolimus prolongs corneal allograft survival and prevents dendritic cell infiltration in a myeloid-derived suppressor cell–dependent manner
- Open Access
- 16 January 2022
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 36 (2) , e24238
Diagnostic value of Lipoarabinomannan antigen for detecting Mycobacterium tuberculosis in adults and children with or without HIV infection
Objectives: Even today, tuberculosis (TB) remains a leading public health problem; yet, the current diagnostic methods still have a few shortcomings. Lipoarabinomannan (LAM) provides an opportunity for TB diagnosis, and urine LAM detection seems to have a promising and widely applicable prospect.Design or methods: Four databases were systematically searched for eligible studies, and the quality of the studies was evaluated using the quality assessment of diagnostic accuracy studies‐2 (QUADAS‐2). Graphs and tables were created to show sensitivity, specificity, likelihood ratios, diagnostic odds ratio (DOR), the area under the curve (AUC), and so on.Results: Based on the included 67 studies, the pooled sensitivity of urine LAM was 48% and specificity was 89%. In the subgroup analyses, the FujiLAM test had higher sensitivity (69%) and specificity (92%). Furthermore, among patients infected with human immunodeficiency virus (HIV), 50% of TB patients were diagnosed using a urine LAM test. Besides, the CD4+ cell count was inversely proportional to the sensitivity.Conclusions: Urine LAM is a promising diagnostic test for TB, particularly using the FujiLAM in HIV‐infected adults whose CD4+ cell count is ≤100 per μl. Besides, the urine LAM test shows various sensitivities and specificities in different subgroups in terms of age, HIV infection status, CD4+ cell count, and testing method.
- 16 January 2022
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 36 (2) , e24238
Open AccessDiagnostic value of Lipoarabinomannan antigen for detecting Mycobacterium tuberculosis in adults and children with or without HIV infection
Objectives: Even today, tuberculosis (TB) remains a leading public health problem; yet, the current diagnostic methods still have a few shortcomings. Lipoarabinomannan (LAM) provides an opportunity for TB diagnosis, and urine LAM detection seems to have a promising and widely applicable prospect.Design or methods: Four databases were systematically searched for eligible studies, and the quality of the studies was evaluated using the quality assessment of diagnostic accuracy studies‐2 (QUADAS‐2). Graphs and tables were created to show sensitivity, specificity, likelihood ratios, diagnostic odds ratio (DOR), the area under the curve (AUC), and so on.Results: Based on the included 67 studies, the pooled sensitivity of urine LAM was 48% and specificity was 89%. In the subgroup analyses, the FujiLAM test had higher sensitivity (69%) and specificity (92%). Furthermore, among patients infected with human immunodeficiency virus (HIV), 50% of TB patients were diagnosed using a urine LAM test. Besides, the CD4+ cell count was inversely proportional to the sensitivity.Conclusions: Urine LAM is a promising diagnostic test for TB, particularly using the FujiLAM in HIV‐infected adults whose CD4+ cell count is ≤100 per μl. Besides, the urine LAM test shows various sensitivities and specificities in different subgroups in terms of age, HIV infection status, CD4+ cell count, and testing method.
- Open Access
- 1 January 2022
- Published by XMLink in Yonsei Medical Journal
- Vol. 63 (1) , 95-103
Meta-Analysis of the Diagnostic Efficacy of the Luminex xTAG Respiratory Viral Panel FAST v2 Assay for Respiratory Viral Infections
Xie LM, et al. Yonsei Med J. 2022 Jan;63(1):95-103. https://doi.org/10.3349/ymj.2022.63.1.95
- 1 January 2022
- Published by XMLink in Yonsei Medical Journal
- Vol. 63 (1) , 95-103
Open AccessMeta-Analysis of the Diagnostic Efficacy of the Luminex xTAG Respiratory Viral Panel FAST v2 Assay for Respiratory Viral Infections
Xie LM, et al. Yonsei Med J. 2022 Jan;63(1):95-103. https://doi.org/10.3349/ymj.2022.63.1.95